blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1667712

EP1667712 - B. PERTUSSIS ANTIGENS AND USE THEREOF IN VACCINATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.05.2011
Database last updated on 03.09.2024
Most recent event   Tooltip05.07.2013Lapse of the patent in a contracting state
New state(s): PT		published on 07.08.2013  [2013/32]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals s.a.
rue de l'Institut 89
1330 Rixensart / BE
[2010/29]
Former [2006/24]For all designated states
Glaxosmithkline Biologicals S.A.
Rue de l'Institut 89
1330 Rixensart / BE
Inventor(s)01 / CASTADO, Cindy, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
02 / DENOEL, Philippe, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
03 / GODFROID, Fabrice, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
04 / POOLMAN, Jan, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
 [2010/29]
Former [2006/24]01 / CASTADO, Cindy, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
02 / DENOEL, Philippe, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
03 / GODFROID, Fabrice, GlaxoSmithKline Biologicals sa
Rue de l'Institut 89
B-1330 Rixensart / BE
04 / POOLMAN, Jan, GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
B-1330 Rixensart / BE
Representative(s)Lubienski, Michael John, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 8GS / GB
[N/P]
Former [2006/24]Lubienski, Michael John, et al
GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date04765806.701.10.2004
[2006/24]
WO2004EP11082
Priority number, dateGB2003002311302.10.2003         Original published format: GB 0323113
GB2003002311202.10.2003         Original published format: GB 0323112
[2006/24]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005032584
Date:14.04.2005
Language:EN
[2005/15]
Type: A2 Application without search report 
No.:EP1667712
Date:14.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2005 takes the place of the publication of the European patent application.
[2006/24]
Type: B1 Patent specification 
No.:EP1667712
Date:21.07.2010
Language:EN
[2010/29]
Search report(s)International search report - published on:EP10.11.2005
ClassificationIPC:A61K39/10
[2006/24]
CPC:
A61K39/099 (EP,US); Y02A50/30 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/24]
Extension statesALNot yet paid
HR22.03.2006
LT22.03.2006
LV22.03.2006
MKNot yet paid
TitleGerman:B. PERTUSSIS ANTIGENE UND IHRE VERWENDUNG BEI DER VAKZINIERUNG[2006/24]
English:B. PERTUSSIS ANTIGENS AND USE THEREOF IN VACCINATION[2006/24]
French:ANTIGENES DE B. PERTUSSIS ET LEUR UTILISATION DANS LA VACCINATION[2006/24]
Entry into regional phase22.03.2006National basic fee paid 
22.03.2006Designation fee(s) paid 
22.03.2006Examination fee paid 
Examination procedure10.10.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.03.2006Examination requested  [2006/24]
31.07.2007Despatch of a communication from the examining division (Time limit: M06)
11.02.2008Reply to a communication from the examining division
09.04.2008Despatch of a communication from the examining division (Time limit: M06)
20.10.2008Reply to a communication from the examining division
21.01.2009Despatch of a communication from the examining division (Time limit: M04)
29.05.2009Reply to a communication from the examining division
27.01.2010Communication of intention to grant the patent
28.05.2010Fee for grant paid
28.05.2010Fee for publishing/printing paid
Opposition(s)26.04.2011No opposition filed within time limit [2011/26]
Fees paidRenewal fee
05.10.2006Renewal fee patent year 03
15.10.2007Renewal fee patent year 04
07.10.2008Renewal fee patent year 05
07.10.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
PT21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
TR21.07.2010
IE01.10.2010
LU01.10.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
HU22.01.2011
[2013/32]
Former [2012/47]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
TR21.07.2010
IE01.10.2010
LU01.10.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
HU22.01.2011
Former [2012/44]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
IE01.10.2010
LU01.10.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
HU22.01.2011
Former [2012/42]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
IE01.10.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
HU22.01.2011
Former [2011/47]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
IE01.10.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2011/38]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
BG21.10.2010
GR22.10.2010
CH31.10.2010
LI31.10.2010
MC31.10.2010
Former [2011/32]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
RO21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
BG21.10.2010
GR22.10.2010
MC31.10.2010
Former [2011/24]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
BG21.10.2010
GR22.10.2010
MC31.10.2010
Former [2011/23]AT21.07.2010
CY21.07.2010
CZ21.07.2010
DK21.07.2010
EE21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SE21.07.2010
SI21.07.2010
SK21.07.2010
BG21.10.2010
GR22.10.2010
Former [2011/19]AT21.07.2010
CY21.07.2010
DK21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SE21.07.2010
SI21.07.2010
BG21.10.2010
GR22.10.2010
Former [2011/15]AT21.07.2010
CY21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SE21.07.2010
SI21.07.2010
BG21.10.2010
GR22.10.2010
Former [2011/13]AT21.07.2010
CY21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SI21.07.2010
BG21.10.2010
Former [2011/11]AT21.07.2010
FI21.07.2010
NL21.07.2010
PL21.07.2010
SI21.07.2010
BG21.10.2010
Former [2011/08]AT21.07.2010
NL21.07.2010
Cited inInternational search[A]US5885587  (ECKHARDT THOMAS G [US], et al) [A] 1-70 * abstract *;
 [X]  - FERNANDEZ R C ET AL, "CLONING AND SEQUENCING OF A BORDETELLA PERTUSSIS SERUM RESISTANCE LOCUS", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, (199411), vol. 62, no. 11, ISSN 0019-9567, pages 4727 - 4738, XP000971412 [X] 1-70 * figure 4 * * page 4731, column R * * page 4736, column R, paragraph L *
 [A]  - PARKHILL J ET AL, "COMPARATIVE ANALYSIS OF THE GENOME SEQUENCES OF BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA", NATURE GENETICS, NATURE AMERICA, NEW YORK, US, (200309), vol. 35, no. 1, ISSN 1061-4036, pages 32 - 40, XP008044372 [A] 1-70 * the whole document *

DOI:   http://dx.doi.org/10.1038/ng1227
 [A]  - HEININGER ULRICH ET AL, "Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection", CLINICAL INFECTIOUS DISEASES, (199903), vol. 28, no. 3, ISSN 1058-4838, pages 602 - 604, XP008044356 [A] 1-70 * page 604, column L, paragraph L *
Examination   - FRITS R. MOOI ET AL., "Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?", EMERGING INFECTIOUS DISEASE, (200106), vol. 7, no. 3, pages 526 - 528
    - JAN T POOLMAN ET AL., "Acellular pertussis vaccines and the role of pertactin and fimbriae", EXPERT REVIEW VACCINES, (2007), vol. 6, no. 1, pages 47 - 56
    - DAVID C. OLIVER ET AL., "Antibodies to BrkA augment killing of Bordetella pertussis", VACCINE, (2002), vol. 20, pages 235 - 241
by applicantGB222021
 US4365170
 EP0161188
 EP0208375
 US4673574
 US4709017
 WO9006951
 US4946778
 US4950740
 WO9013312
 EP0424518
 US5057540
 WO9201460
 WO9203467
 EP0477508
 WO9306861
 WO9315760
 WO9400153
 EP0586266
 WO9422914
 WO9517209
 WO9517210
 EP0689454
 WO9602555
 WO9605859
 WO9629412
 WO9633739
 WO9640928
 WO9709994
 EP0689454
 WO9741151
 WO9802547
 EP0834568
 EP0837130
 WO9818930
 WO9818931
 US5766608
 US5804193
 US5843711
 US5843464
 WO9903884
 WO9909176
 US5885587
 US5912336
 WO9931132
 US5917017
 WO9951266
 WO9955873
 US6342224
 US6455673
    - STORSAETER ET AL., VACCINE, (1998), vol. 16, page 1907
    - LAUTROP, LANCET, (1971), vol. 1, no. 7711, pages 1195 - 1198
    - GENE, (1986), vol. 43, pages 265 - 272
    - MOOI ET AL., EMERGING INFECTIOUS DISEASES, (2001), vol. 7, page 526
    - FROHMAN ET AL., PNAS USA, (1988), vol. 85, pages 8998 - 9002
    - STOCKBAUER ET AL., MOLECULAR MICROBIOLOGY, (2001), vol. 39, pages 65 - 78
    - MOOI ET AL., MICROB PATHOG, (1992), vol. 12, pages 127 - 135
    - FEMANDEZ ET AL., INFECTION AND IMMUNITY, (1994), vol. 62, pages 4727 - 4738
    - WILSON ET AL., CELL, (1984), vol. 37, page 767
    - LIVEY, J. MED. MICROBIOL., (1984), vol. 17, pages 91 - 103
    - WOLFF ET AL., HUM MOL GENET, (1992), vol. 1, page 363
    - WEISS, ASM NEWS, (1997), vol. 63, page 22
    - WU ET AL., JBIOL CHEM., (1989), vol. 264, page 16985
    - FERNANDEZ; WEISS, INFECTION AND IMMUNITY, (1994), vol. 62, page 4727
    - KANEDA ET AL., SCIENCE, (1989), vol. 243, page 375
    - COTTON, PROC. NATL. ACAD. SCI., USA, (1985), vol. 85, pages 4397 - 4401
    - EISENBRAUN ET AL., DNA CELL BIOL, (1993), vol. 12, page 791
    - UCHIDA ET AL., J. BIOL. CHEM., (1973), vol. 218, pages 3838 - 3844
    - MITCHELL ET AL., NUCLEIC ACIDS RES., (19900711), vol. 18, no. 13, page 4010
    - FINN; STEVENS, MOL. MICROBIOL., (1995), vol. 16, pages 625 - 634
    - BERRY; PATON, INFECT IMMUN, (199612), vol. 64, no. 12, pages 5255 - 62
    - INFECTION AND IMMUNITY, (2001), vol. 69, page 6951
    - SANCHEZ-BEATO ET AL., FEMS MICROBIOL LETT, (1998), vol. 164, pages 207 - 14
    - ANNU REV CELL DEV BIOL., (2000), vol. 16, pages 423 - 457
    - FERNANDEZ ET AL., INFECTION AND IMMUNITY, (1994), vol. 62, pages 4727 - 4738
    - MOL. MICROBIOL., (1997), vol. 23, pages 879 - 892
    - MUNOZ ET AL., INFECT IMMUN, (1981), vol. 33, pages 820 - 826
    - VAN ULSEN ET AL., IMMUNOL. MED. MICROBIOL., (2001), vol. 32, pages 53 - 64
    - YUK ET AL., MOL. MICROBIOL., (2000), vol. 35, pages 991 - 1004
    - INFECTION AND IMMUNITY, (2002), vol. 70, no. 8, pages 4447 - 4461
    - DEORA ET AL., MOLECULAR MICROBIOLOGY, (2001), vol. 40, pages 669 - 683
    - MOL MICROBIOL., (1997), vol. 23, pages 737 - 749
    - SCARLATO; RAPPUOLI, J. BACTERIOL., (1991), vol. 173, pages 7401 - 7404
    - MASIGNANI ET AL., INTERNATIONAL PATHOGENIC NEISSERIA CONFERENCE, (2002), page 135
    - PERSSON, EUR. RESPIR., (1991), vol. 4, page 1268
    - MOSMANN, TR; COFFMAN, R.L., "THl and TH2 cells: different patterns of lymphokine secretion lead to different functional properties", ANNUAL REVIEW OF IMMUNOLOGY, (1989), vol. 7, pages 145 - 173
    - COLE ET AL., MONOCLONAL ANTIBODIES AND CANCER THERAPY, ALAN R. LISS, INC., (1985), pages 77 - 96
    - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
    - MARKS ET AL., BIOTECHNOLOGY, (1992), vol. 10, pages 779 - 783
    - PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 2444 - 2448
    - ALTSCHUL, S. ET AL., BLAST Manual, NCBI NLM NIH
    - TEMPEST ET AL., BIOTECHNOLOGY, (1991), vol. 9, pages 266 - 273
    - COLIGAN ET AL., Current Protocols in Immunology, (1991), vol. 1
    - PROC. NATL. ACAD. SCI. USA., (1992), vol. 89, pages 10915 - 10919
    - K. JOHANSON ET AL., J BIOL CHEM, (1995), vol. 270, no. 16, pages 9459 - 9471
    - OKANO, NEUROCHEM., (1991), vol. 56, page 560
    - ZHOU, L ET AL., FEMS MICROBIOL. LETT., (1998), vol. 163, pages 223 - 228
    - SATO, Y. ET AL., SCIENCE, (1996), vol. 273, page 352
    - CHU C. ET AL., INFECT. IMMUNITY, (1983), pages 245 - 256
    - MITCHELL ET AL., BIOCHIM BIOPHYS ACTA, (19890123), vol. 1007, no. 1, pages 67 - 72
    - INFECT. IMMUN., (1996), vol. 64, page 3544
    - J. EXP.MED, (2002), vol. 195, page 1445
    - NATURE BIOTECH, (2002), vol. 20, pages 914 - 921
    - ULSEN ET AL., IMMUNOL. MED. MICROBIOL., (2001), vol. 32, pages 53 - 64
    - COMANDUCCI ET AL., J. EXP. MED., (2002), vol. 195, pages 1445 - 1454
    - MED MICROBIOL, (1999), vol. 32, page 1117
    - TETTELIN ET AL., SCIENCE, (2000), vol. 287, pages 1809 - 1815
    - R. GLUCK, VACCINE, (1992), vol. 10, pages 915 - 920
    - MOSMANN, TR.; COFFMAN, R.L., "THI and TH2 cells: different patterns of lymphokine secretion lead to different functional properties", ANNUAL REVIEW OFLMMUNOLOGY, (1989), vol. 7, pages 145 - 173
    - CARILLO, H.; LIPMAN, D., SIAM J APPLIED MATH., (1988), vol. 48, page 1073
    - ALTSCHUL, S.F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
    - ALTSCHUL, S. ET AL., J MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - NEEDLEMAN; WUNSCH, J. MOL BIOL., (1970), vol. 48, pages 443 - 453
 WO1999US30390
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.